Image Credit: STAT News
STAT+: Germany’s ITM, a stalwart in radiopharmaceuticals, gets ready to take its own shots
Germany’s ITM, a stalwart in the highly specialized field of radiopharmaceuticals, will soon announce the results from its first Phase 3 trial.